How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/staphylococcal-prosthetic-heart-valve-endocarditis.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Staphylococcal Prosthetic Heart Valve Endocarditis — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Staphylococcal Prosthetic Heart Valve Endocarditis (disease) competitive landscape: 4 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

4 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Staphylococcal Prosthetic Heart Valve Endocarditis, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Bactocill In Plastic Container	OXACILLIN	Apothecon		Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A, Prostaglandin G/H synthase 1, Prostaglandin G/H synthase 2	1971-01-01
Nallpen In Plastic Container	NAFCILLIN SODIUM	Pfizer	Penicillin-class Antibacterial		1965-01-01
Nallpen In Plastic Container	NAFCILLIN	Pfizer	Penicillin-class Antibacterial		1965-01-01
Vancocin	vancomycin	ANI Pharmaceuticals		Alpha-2A adrenergic receptor, D-alanyl-D-alanine dipeptidase, UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Pfizer · 2 drugs in Staphylococcal Prosthetic Heart Valve Endocarditis
ANI Pharmaceuticals · 1 drug in Staphylococcal Prosthetic Heart Valve Endocarditis
Apothecon · 1 drug in Staphylococcal Prosthetic Heart Valve Endocarditis

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Staphylococcal Prosthetic Heart Valve Endocarditis:

Cite this brief

Drug Landscape (2026). Staphylococcal Prosthetic Heart Valve Endocarditis — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/staphylococcal-prosthetic-heart-valve-endocarditis. Accessed 2026-06-10.

Staphylococcal Prosthetic Heart Valve Endocarditis full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing